These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23379510)

  • 1. Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients.
    Lai CC; Sheng WH; Wang JT; Cheng A; Chuang YC; Chen YC; Chang SC
    BMC Infect Dis; 2013 Feb; 13():66. PubMed ID: 23379510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections.
    Timerman A; Brites C; Bicudo E; Grinbaum RS; Costa Filho R; Carrilho CD; Bichels A; Barreto T
    Braz J Infect Dis; 2013; 17(6):647-53. PubMed ID: 23916455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.
    Seaton RA; Menichetti F; Dalekos G; Beiras-Fernandez A; Nacinovich F; Pathan R; Hamed K
    Adv Ther; 2015 Dec; 32(12):1192-205. PubMed ID: 26610384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.
    Seaton RA; Gonzalez-Ruiz A; Cleveland KO; Couch KA; Pathan R; Hamed K
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():18. PubMed ID: 26976128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
    Gonzalez-Ruiz A; Gargalianos-Kakolyris P; Timerman A; Sarma J; José González Ramallo V; Bouylout K; Trostmann U; Pathan R; Hamed K
    Adv Ther; 2015 Jun; 32(6):496-509. PubMed ID: 26108157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections.
    Lai CC; Sheng WH; Wang JT; Liao CH; Ho MW; Chen CJ; Chen DL; Chou MU; Lee CM; Lin YC; Pong MY; Chang SC
    J Microbiol Immunol Infect; 2012 Feb; 45(1):52-7. PubMed ID: 22153759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.
    Kullar R; Casapao AM; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    J Antimicrob Chemother; 2013 Dec; 68(12):2921-6. PubMed ID: 23928022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents.
    Syriopoulou V; Dailiana Z; Dmitriy N; Utili R; Pathan R; Hamed K
    Pediatr Infect Dis J; 2016 May; 35(5):511-6. PubMed ID: 26849158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy and safety of daptomycin for the treatment of Gram-positive bacterial infections in Chinese population].
    Zhang L; Li J; Wan X; Shen J; Liu H; Gao H; Liu Z; Wang A
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):496-500. PubMed ID: 26359009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.
    Knapp AG; Kamepalli RK; Martone WJ; Yankelev S
    Surg Infect (Larchmt); 2011 Apr; 12(2):113-8. PubMed ID: 21348765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections.
    Slim J; Jimenez H; Culshaw D; Patel H; Lamp KC
    J Int Assoc Provid AIDS Care; 2015; 14(3):202-6. PubMed ID: 25320146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin experience in critical care patients: results from a registry.
    Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
    Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin.
    Enoch DA; Bygott JM; Daly ML; Karas JA
    J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
    Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S
    Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with daptomycin in Europe: the first 2.5 years.
    Gonzalez-Ruiz A; Beiras-Fernandez A; Lehmkuhl H; Seaton RA; Loeffler J; Chaves RL
    J Antimicrob Chemother; 2011 Apr; 66(4):912-9. PubMed ID: 21393205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.